Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

China

The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei

The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality

Tianjin People's Hospital, Tianjin, Tianjin Municipality